LivaNova PLC Stock News

LivaNova (LIVN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ro

LivaNova (LIVN) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.81 per share a year ago.

LivaNova is approaching the end of the ANTHEM and RECOVER which could dramatically change the company profile. In cardiopulmonary results are great with a new product launch of Essenz taking market sh

LivaNova PLC (NASDAQ:LIVN ) Q3 2023 Earnings Conference Call November 1, 2023 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development & IT Bill Cozy - Chairman and

Investors always hope to buy low and sell high. In order to do so, it's necessary to identify stocks that are undervalued.

LivaNova (LIVN) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.53 per share a year ago.

Media-shy investment firm PRIMECAP Management (Trades, Portfolio) revealed earlier this week it upped its stake in LivaNova PLC ( LIVN , Financial), which had an impact of 0.04% on the equity portfoli

LivaNova PLC (NASDAQ:LIVN ) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development William Kozy - Chairman & Interi

LivaNova (LIVN) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.48 per share a year ago.

LivaNova (LIVN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in

After losing some value lately, a hammer chart pattern has been formed for LivaNova (LIVN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisi

LivaNova (LIVN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates

LivaNova (LIVN) delivered earnings and revenue surprises of 12.50% and 4.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

LivaNova provides high-tech medical devices for the benefit of healthcare professionals, patients, and healthcare systems around the world. Considering the geographic diversification of the business m

LONDON--( BUSINESS WIRE )--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth-quarter and full-year 2022 results